Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01556490
Title Efficacy Evaluation of TheraSphere in Patients With Inoperable Liver Cancer
Acronym STOP-HCC
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors BTG International Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA | NLD | ITA | GBR | FRA | ESP | DEU | CAN | BEL


No variant requirements are available.